MXPA03001432A - Uso de sulfoxidos de triazintriona para controlar coccidiosis. - Google Patents

Uso de sulfoxidos de triazintriona para controlar coccidiosis.

Info

Publication number
MXPA03001432A
MXPA03001432A MXPA03001432A MXPA03001432A MXPA03001432A MX PA03001432 A MXPA03001432 A MX PA03001432A MX PA03001432 A MXPA03001432 A MX PA03001432A MX PA03001432 A MXPA03001432 A MX PA03001432A MX PA03001432 A MXPA03001432 A MX PA03001432A
Authority
MX
Mexico
Prior art keywords
triazinetrione
sulfoxides
coccidioses
controlling
controlling coccidioses
Prior art date
Application number
MXPA03001432A
Other languages
English (en)
Inventor
Hans-Christian Mundt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MXPA03001432A publication Critical patent/MXPA03001432A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere al uso de derivados especificos de triazintrionas para controlar la coccidiosis en animales, especialmente cerdos.
MXPA03001432A 2000-08-17 2001-08-10 Uso de sulfoxidos de triazintriona para controlar coccidiosis. MXPA03001432A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040110A DE10040110A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
PCT/EP2001/009244 WO2002013831A1 (de) 2000-08-17 2001-08-10 Verwendung von triazintrion-sulfoxiden zur bekämpfung von coccidiosen

Publications (1)

Publication Number Publication Date
MXPA03001432A true MXPA03001432A (es) 2004-05-04

Family

ID=7652673

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001432A MXPA03001432A (es) 2000-08-17 2001-08-10 Uso de sulfoxidos de triazintriona para controlar coccidiosis.

Country Status (14)

Country Link
US (1) US20030181451A1 (es)
EP (1) EP1311271A1 (es)
JP (1) JP2004506016A (es)
KR (1) KR20030019903A (es)
CN (1) CN1469747A (es)
AU (1) AU2001293751A1 (es)
BR (1) BR0113294A (es)
CA (1) CA2419414A1 (es)
DE (1) DE10040110A1 (es)
HU (1) HUP0301561A3 (es)
MX (1) MXPA03001432A (es)
PL (1) PL360630A1 (es)
WO (1) WO2002013831A1 (es)
ZA (1) ZA200301226B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102285930B (zh) * 2011-08-12 2013-07-03 中国农业科学院上海兽医研究所 一种三嗪化合物及其在控制鸡球虫病中的应用
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
MA52415A (fr) 2018-02-26 2021-01-06 AlzeCure Pharma AB Dérivés de triazine pour le traitement de maladies associées à des neurotrophines
EP3578181A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3408768A1 (de) * 1984-03-09 1985-09-12 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US5859028A (en) * 1997-04-28 1999-01-12 Potomax Limited Partnership Carotenoid synthesis inhibiting herbicides and fatty acid synthesis inhibiting oxime herbicides as anti-Apicomplexa protozoan parasite agents
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
EP1140101A1 (en) * 1998-12-22 2001-10-10 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma

Also Published As

Publication number Publication date
US20030181451A1 (en) 2003-09-25
WO2002013831A1 (de) 2002-02-21
CA2419414A1 (en) 2002-02-21
BR0113294A (pt) 2003-07-08
EP1311271A1 (de) 2003-05-21
HUP0301561A3 (en) 2004-11-29
HUP0301561A2 (hu) 2003-09-29
ZA200301226B (en) 2004-02-16
KR20030019903A (ko) 2003-03-07
JP2004506016A (ja) 2004-02-26
DE10040110A1 (de) 2002-02-28
PL360630A1 (en) 2004-09-20
CN1469747A (zh) 2004-01-21
AU2001293751A1 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
MXPA03000081A (es) Composiciones para el tratamiento del agua.
MY135233A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
ZA200306886B (en) Pyrazolopyrimidines as therapeutic agents.
TW200637522A (en) Skin treatment articles and methods
ZA200205887B (en) Liver tissue source.
MXPA02002898A (es) Pirazolopirimidinas como agentes terapeuticos.
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
MXPA03002080A (es) Derivados de resorcinol.
ZA200106160B (en) Compositions and methods for treating cataracts.
HK1061021A1 (en) Pyrazole derivatives for the treatment of viral diseases.
MXPA03001983A (es) Exemestano como agente quimiopreventivo.
AU2001280997A1 (en) High-strength, stabilized absorbent article
HK1069171A1 (en) Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents.
GC0000155A (en) 6-Hydroxy-indazole derivatives for treating glaucoma.
ZA200207489B (en) Apomorphine derivatives and methods for their use.
ITMI20010186V0 (it) Cerniera, specialmente per mobili
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
MY136518A (en) Use of triazine trione sulphones for controlling coccidioses
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
MXPA03007314A (es) Composicion para la piel para reducir aceites y grasa de la piel.
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
HK1052925A1 (en) Substituted 1-aminobutan-3-ol derivatives.
MXPA03001432A (es) Uso de sulfoxidos de triazintriona para controlar coccidiosis.